phenylalanine has been researched along with Diabetes Mellitus in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (32.65) | 18.7374 |
1990's | 2 (4.08) | 18.2507 |
2000's | 20 (40.82) | 29.6817 |
2010's | 10 (20.41) | 24.3611 |
2020's | 1 (2.04) | 2.80 |
Authors | Studies |
---|---|
Braegelman, AS; Camden, JP; Olson, JE; Webber, MJ; Zou, L | 1 |
Angayarkanni, N; Radhakrishnan, S; Srinivasan, V; Sulochana, KN | 1 |
Brancati, FL; Califf, RM; Chatterjee, R; Edelman, D; Svetkey, L; Thomas, L | 1 |
Chino, Y; Goto, D; Hayashi, T; Ito, S; Kondo, Y; Matsumoto, I; Ogishima, H; Sugihara, M; Sumida, T | 1 |
Kataoka, Y; Kimura, K; Kosuge, M; Miyamoto, Y; Miyazaki, S; Sase, K; Yasuda, S; Yoshimasa, Y | 2 |
Adamski, J; Ala-Korpela, M; Artati, A; Casas, JP; Chaturvedi, N; Gaunt, TR; Gerszten, RE; Ghorbani, A; Havulinna, AS; Hughes, AD; Illig, T; Jula, A; Kähönen, M; Kaikkonen, J; Kangas, AJ; Kettunen, J; Lawlor, DA; Lehtimäki, T; Mikkilä, V; Perola, M; Prieto-Merino, D; Raitakari, OT; Ripatti, S; Salomaa, V; Sattar, N; Soininen, P; Tiainen, M; Tillin, T; Tynkkynen, T; Vasan, RS; Wang, Q; Wang, TJ; Würtz, P | 1 |
Inagaki, N; Nagashima, K | 1 |
Arai, T; Honjo, T; Ishioka, K; Lee, P; Miki, Y; Mizutani, H; Mori, A; Nishimaki, Y; Oda, H; Saeki, K; Sako, T; Yamashita, T | 1 |
Bethel, MA; Califf, RM; Gerlock, T; Haffner, SM; Holman, RR; Holzhauer, B; Horton, E; Krum, H; McMurray, JJ; Zuurman, L | 1 |
Ory, DS; Schaffer, JE | 1 |
Busse, R; Kreis, J | 1 |
Masuzaki, H; Sata, M; Shimabukuro, M | 1 |
Iguchi, A; Satake, S | 1 |
Birkeland, KI; Bleskestad, IH | 1 |
Yamada, K | 1 |
Ferriman, A | 1 |
Ishida, H; Kadowaki, T; Kawamori, R | 1 |
Chu, YC; Hu, SQ; Katsoyannis, PG; Nakagawa, SH; Wang, RY; Wang, S; Weiss, MA; Xu, B | 1 |
Chu, YC; Hu, SQ; Huang, K; Katsoyannis, PG; Nakagawa, SH; Weiss, MA; Whittaker, J; Xu, B | 1 |
Ceballos, G; Guzman-Grenfell, AM; Hicks, JJ; Olivares-Corichi, IM; Ortega-Camarillo, C | 1 |
Fang, Q; Lin, X; Wang, C; Xiang, K; Zhang, R | 1 |
Byun, J; Danda, R; Heinecke, JW; Heller, JI; Ido, Y; Pennathur, S; Pergola, P; Williamson, JR | 1 |
Denecke, J; Feldmann, R; Grenzebach, M; Weglage, J | 1 |
Ishimaru, M; Nagawa, H; Suzuki, T; Yamaguchi, H; Yamashita, H; Yamauchi, H | 1 |
Makino, C; Ninomiya, N; Okano, A; Orita, H; Sakai, H; Yabuki, A | 1 |
Ashcroft, FM; Baevre, H; Girard, C; Njølstad, PR; Proks, P | 1 |
Fan, L; Han, CT; He, YJ; Hu, DL; Li, Q; Liu, ZQ; Tan, ZR; Wang, D; Yu, BN; Zhang, W; Zhang, WX; Zhou, HH | 1 |
Duffy, NA; Flatt, PR; Gault, VA; Green, BD; Irwin, N; McKillop, AM; O'Harte, FP | 1 |
Chan, SJ; Kwok, SC; Poucher, R; Rubenstein, AH; Steiner, DF | 1 |
Korc, M | 1 |
Kwok, SC; Rubenstein, AH; Steiner, DF; Tager, HS | 1 |
Bjorkling, F; Ladriere, L; Malaisse, WJ | 1 |
Ladrière, L; Laghmich, A; Malaisse, WJ; Malaisse-Lagae, F | 1 |
Aljada, A; Assian, E; Dandona, P; Garg, R; Ghanim, H; Hamouda, W; Mohanty, P | 1 |
Koivisto, V | 1 |
Curzon, G; Fernando, JC; Knott, PJ | 1 |
Lay, A; Menge, H; Riecken, EO; Zennek, A | 1 |
Bleicher, SJ; Flores, A; Gombos, G; Recitas, D; Shu, J; Stern, SB | 1 |
Hasche, H; Willms, B | 1 |
Chang, AY | 1 |
Pain, VM | 2 |
Clemens, MJ; Pain, VM | 1 |
Gylfe, E | 1 |
Reed, AH | 1 |
Cohen, MP; Grinblat, L | 1 |
Greene, WC; Peterson, DT; Reaven, GM | 1 |
Appel, W; Hermann, H; Huth, E | 1 |
4 review(s) available for phenylalanine and Diabetes Mellitus
Article | Year |
---|---|
[Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents].
Topics: Administration, Oral; Cyclohexanes; Diabetes Mellitus; Glyburide; Humans; Hypoglycemic Agents; Infant, Newborn; Insulin; Insulin Secretion; KATP Channels; Mutation; Nateglinide; Phenylalanine; Stimulation, Chemical; Sulfonylurea Compounds | 2009 |
[Management guideline for elderly diabetic patients].
Topics: Aged; Cyclohexanes; Diabetes Mellitus; Diet, Diabetic; Exercise Therapy; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Metformin; Nateglinide; Phenylalanine; Practice Guidelines as Topic; Sulfonylurea Compounds | 2002 |
[Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
Topics: Acarbose; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypertension; Hypoglycemic Agents; Inositol; Insulin Resistance; Nateglinide; Obesity; Phenylalanine; Postprandial Period | 2003 |
[Insulin analogs and new oral antidiabetic drugs].
Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Dose-Response Relationship, Drug; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |
5 trial(s) available for phenylalanine and Diabetes Mellitus
Article | Year |
---|---|
Effects of changes in potassium with valsartan use on diabetes risk: Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
Topics: Antihypertensive Agents; Biomarkers; Cyclohexanes; Diabetes Mellitus; Female; Follow-Up Studies; Glucose Intolerance; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Potassium; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2013 |
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Patient Selection; Phenylalanine; Prediabetic State; Research Design; Risk Assessment; Risk Factors; Tetrazoles; Valine; Valsartan | 2010 |
Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early-stage diabetic patients.
Topics: Aged; Coronary Artery Disease; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Female; Glycemic Index; Humans; Hypoglycemic Agents; Inositol; Male; Middle Aged; Nateglinide; Phenylalanine | 2012 |
Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?
Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; C-Reactive Protein; Chemokine CCL2; Cholesterol; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Humans; I-kappa B Proteins; Insulin; Intercellular Adhesion Molecule-1; Leukocytes, Mononuclear; Linoleic Acid; Linoleic Acids; Linoleic Acids, Conjugated; Male; Middle Aged; NADPH Oxidases; Neutrophils; NF-kappa B; Obesity; Phenylalanine; Phosphoproteins; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Tyrosine | 2001 |
Administration of aspartame in non-insulin-dependent diabetics.
Topics: Adult; Aged; Aspartame; Blood Glucose; Diabetes Mellitus; Dipeptides; Female; Humans; Male; Middle Aged; Phenylalanine; Placebos; Tyrosine | 1976 |
40 other study(ies) available for phenylalanine and Diabetes Mellitus
Article | Year |
---|---|
Capture of Phenylalanine and Phenylalanine-Terminated Peptides Using a Supramolecular Macrocycle for Surface-Enhanced Raman Scattering Detection.
Topics: Diabetes Mellitus; Humans; Macrocyclic Compounds; Metal Nanoparticles; Peptides; Phenylalanine; Phenylketonurias; Silver; Spectrum Analysis, Raman | 2020 |
Antidiabetic effect of free amino acids supplementation in human visceral adipocytes through adiponectin-dependent mechanism.
Topics: Adipocytes; Adiponectin; Amino Acids; AMP-Activated Protein Kinase Kinases; Cells, Cultured; Diabetes Mellitus; Dietary Supplements; Gene Expression Regulation; Glucose; Humans; Hypoglycemic Agents; Intra-Abdominal Fat; Obesity; Phenylalanine; Proline; Protein Kinases; RNA, Messenger; RNA, Small Interfering; Signal Transduction | 2019 |
Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases.
Topics: Acarbose; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Glucose; Connective Tissue Diseases; Cyclohexanes; Diabetes Mellitus; Early Diagnosis; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Phenylalanine; Prednisolone; Treatment Outcome | 2014 |
Clinical predictors of atheroma progression despite optimal glycemic control in early-stage diabetic patients with coronary artery disease: Insight from the DIANA study.
Topics: Blood Glucose; Coronary Angiography; Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Life Style; Male; Middle Aged; Nateglinide; Phenylalanine; Plaque, Atherosclerotic; Prospective Studies; Risk Factors; Ultrasonography, Interventional | 2014 |
Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.
Topics: Adolescent; Adult; Age Distribution; Aged; Biomarkers; Blood Pressure; Cardiovascular Agents; Cardiovascular Diseases; Child; Comorbidity; Diabetes Mellitus; Docosahexaenoic Acids; Endophenotypes; Fatty Acids, Monounsaturated; Fatty Acids, Omega-6; Female; Finland; Health Surveys; High-Throughput Screening Assays; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Nuclear Magnetic Resonance, Biomolecular; Phenylalanine; Prospective Studies; Risk Assessment; Risk Factors; Sex Distribution; Smoking; United Kingdom; United States; Young Adult | 2015 |
Effect of glimepiride and nateglinide on serum insulin and glucose concentration in healthy cats.
Topics: Animals; Blood Glucose; Cat Diseases; Cats; Cyclohexanes; Diabetes Mellitus; Female; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Male; Nateglinide; Phenylalanine; Sulfonylurea Compounds | 2009 |
ApoA-1 in diabetes: damaged goods.
Topics: Apolipoprotein A-I; Blood Glucose; Coronary Disease; Diabetes Mellitus; Homeostasis; Humans; Lipoproteins, HDL; Oxidative Stress; Phenylalanine; Risk Factors | 2010 |
From evidence assessments to coverage decisions?: the case example of glinides in Germany.
Topics: Carbamates; Cost Control; Cost-Benefit Analysis; Costs and Cost Analysis; Cyclohexanes; Diabetes Mellitus; Eligibility Determination; Evidence-Based Medicine; Germany; Health Care Reform; Health Policy; Humans; Hypoglycemic Agents; Insurance Coverage; Nateglinide; National Health Programs; Phenylalanine; Piperidines; Prescription Drugs; Reimbursement Mechanisms; Technology Assessment, Biomedical | 2012 |
Intensive glucose lowering in cardiovascular risk management - unsolved questions - .
Topics: Coronary Artery Disease; Cyclohexanes; Diabetes Mellitus; Female; Glycemic Index; Humans; Inositol; Male; Nateglinide; Phenylalanine | 2012 |
[Differences between oral antidiabetics].
Topics: Administration, Oral; Carbamates; Cyclohexanes; Diabetes Mellitus; Glipizide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Sulfonylurea Compounds | 2003 |
Novartis breached code after doctors say it "invented" a disease.
Topics: Advertising; Blood Glucose; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Disclosure; Drug Industry; Europe; Family Practice; Humans; Hyperglycemia; Hypoglycemic Agents; Meta-Analysis as Topic; Nateglinide; Phenylalanine; Prospective Studies; Risk; United Kingdom | 2002 |
[Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
Topics: Administration, Oral; Cardiovascular Diseases; Cyclohexanes; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Indoles; Inositol; Insulin; Insulin Resistance; Insulin Secretion; Isoindoles; Nateglinide; Phenylalanine; Risk Factors; Stimulation, Chemical; Sulfonylurea Compounds; Thiazolidinediones | 2004 |
Diabetes-associated mutations in insulin identify invariant receptor contacts.
Topics: Azides; Binding Sites; Diabetes Mellitus; Humans; Insulin; Molecular Structure; Mutation; Phenylalanine; Receptor, Insulin | 2004 |
Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.
Topics: Amino Acid Sequence; Animals; Azides; Blotting, Western; CHO Cells; Chymotrypsin; Cricetinae; Cross-Linking Reagents; Diabetes Mellitus; Dimerization; Disulfides; Exons; Humans; Insulin; Models, Biological; Models, Molecular; Molecular Sequence Data; Mutation; Phenylalanine; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Receptor, Insulin; Sequence Homology, Amino Acid; Trypsin; Ultraviolet Rays | 2004 |
Reactive oxygen species (ROS) induce chemical and structural changes on human insulin in vitro, including alterations in its immunoreactivity.
Topics: Carbon; Diabetes Mellitus; Epitopes; Formazans; Humans; Hydroxyl Radical; Insulin; Nitroblue Tetrazolium; Oxidative Stress; Phenylalanine; Radioimmunoassay; Reactive Oxygen Species | 2005 |
Scanning for MODY5 gene mutations in Chinese early onset or multiple affected diabetes pedigrees.
Topics: Adenine; Adult; Aged; Amino Acid Substitution; Asian People; Base Sequence; Case-Control Studies; Diabetes Mellitus; DNA-Binding Proteins; Exons; Female; Genetic Testing; Genetic Variation; Guanine; Hepatocyte Nuclear Factor 1-beta; Heterozygote; Humans; Introns; Male; Middle Aged; Molecular Sequence Data; Mutation; Pedigree; Phenylalanine; Promoter Regions, Genetic; Serine; Transcription Factors | 2004 |
Reactive carbonyls and polyunsaturated fatty acids produce a hydroxyl radical-like species: a potential pathway for oxidative damage of retinal proteins in diabetes.
Topics: Amino Acids; Animals; Antioxidants; Carbon; Cerebral Cortex; Chromatography, High Pressure Liquid; Diabetes Mellitus; Diabetes Mellitus, Experimental; Fatty Acids, Unsaturated; Glucose; Guanidines; Hydroxyl Radical; Hyperglycemia; Lipid Metabolism; Lipid Peroxidation; Lipoproteins, LDL; Male; Mass Spectrometry; Oxidative Stress; Oxygen; Phenylalanine; Rats; Rats, Sprague-Dawley; Retina; Ribonuclease, Pancreatic; Temperature; Tyrosine | 2005 |
Frontal lobe-dependent functions in treated phenylketonuria: blood phenylalanine concentrations and long-term deficits in adolescents and young adults.
Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Analysis of Variance; Central Nervous System; Diabetes Mellitus; Female; Frontal Lobe; Humans; Intelligence; Intelligence Tests; Male; Neuropsychological Tests; Phenylalanine; Phenylketonurias; Social Class; Time Factors | 2005 |
Intestinal perforation caused by stagnated press-through packages.
Topics: Aged; Cyclohexanes; Diabetes Mellitus; Drug Packaging; Female; Foreign Bodies; Humans; Hypoglycemic Agents; Intestinal Perforation; Jejunum; Nateglinide; Phenylalanine; Tomography, X-Ray Computed | 2005 |
Effect of decrease in both postprandial blood glucose (PBG) and fasting blood glucose (FBG) levels in normal beagle dogs with nateglinide enteric coated granules and immediate release tablets.
Topics: Administration, Oral; Animals; Blood Glucose; Cyclohexanes; Delayed-Action Preparations; Diabetes Mellitus; Dogs; Fasting; Hydrogen-Ion Concentration; Hypoglycemic Agents; Nateglinide; Phenylalanine; Solubility; Tablets, Enteric-Coated | 2006 |
Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
Topics: Adenosine Triphosphate; Animals; Diabetes Mellitus; Electrophysiology; Female; Heterozygote; Humans; Hypoglycemic Agents; Infant, Newborn; Insulin; Male; Membrane Potentials; Mutation; Oocytes; Phenylalanine; Potassium Channels, Inwardly Rectifying; Sulfonylurea Compounds; Xenopus laevis | 2006 |
Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide.
Topics: Adult; Cyclohexanes; Diabetes Mellitus; Humans; Hypoglycemic Agents; Liver-Specific Organic Anion Transporter 1; Male; Nateglinide; Organic Anion Transporters; Phenylalanine; Polymorphism, Single Nucleotide | 2006 |
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
Topics: Animals; Blood Glucose; Cell Line; Cyclohexanes; Diabetes Mellitus; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Mice; Mice, Obese; Nateglinide; Peptide Fragments; Phenylalanine | 2007 |
Loss of a restriction endonuclease cleavage site in the gene of a structurally abnormal human insulin.
Topics: Base Sequence; Diabetes Mellitus; DNA; DNA Restriction Enzymes; Humans; In Vitro Techniques; Insulin; Leukocytes; Mutation; Phenylalanine | 1981 |
Effect of lanthanum on pancreatic protein synthesis in streptozotocin-diabetic rats.
Topics: Animals; Biological Transport; Calcium; Carbachol; Cholecystokinin; Cycloleucine; Diabetes Mellitus; Insulin; Islets of Langerhans; Kinetics; Lanthanum; Male; Manganese; Peptide Fragments; Phenylalanine; Protein Biosynthesis; Rats; Rats, Inbred Strains; Sincalide | 1983 |
Identification of a point mutation in the human insulin gene giving rise to a structurally abnormal insulin (insulin Chicago).
Topics: Amino Acid Sequence; Diabetes Mellitus; DNA Restriction Enzymes; Humans; Insulin; Leukocytes; Mutation; Phenylalanine | 1983 |
Stimulation of insulin release in hereditarily diabetic rats by mixed molecules formed of nateglinide and a succinic acid ester.
Topics: Animals; Cyclohexanes; Diabetes Mellitus; Hypoglycemic Agents; Insulin; Molecular Structure; Nateglinide; Phenylalanine; Rats; Rats, Inbred Strains; Succinates; Time Factors | 2000 |
Long-term effects of glibenclamide and nateglinide upon pancreatic islet function in normal and diabetic rats.
Topics: Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus; Female; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Nateglinide; Phenylalanine; Rats; Rats, Wistar | 1999 |
The relevance of both plasma free tryptophan and insulin to rat brain tryptophan concentration.
Topics: Animals; Blood-Brain Barrier; Brain; Diabetes Mellitus; Insulin; Male; Phenylalanine; Rats; Streptozocin; Tryptophan; Tyrosine | 1976 |
Quantitative study of mucosal structure, enzyme activities and phenylalanine accumulation in jejunal biopsies of patients with early and late onset diabetes.
Topics: Adult; Aged; Biopsy; Diabetes Mellitus; Female; Humans; Intestinal Mucosa; Jejunum; Male; Middle Aged; Phenylalanine; Sucrase | 1979 |
[Clinical experiences with Des-Phe B1 insulins].
Topics: Blood Glucose; Diabetes Mellitus; Diet; Humans; Insulin; Phenylalanine | 1976 |
Hepatic and renal protein synthesis in normal, diabetic and ketotic Chinese hamsters.
Topics: Amino Acids; Animals; Carbon Radioisotopes; Cricetinae; Diabetes Mellitus; Diabetic Ketoacidosis; Disease Models, Animal; In Vitro Techniques; Kidney; Liver; Phenylalanine; Proteins; Ribosomes | 1974 |
Influence of streptozotocin diabetes on the ability of muscle cell sap to support protein synthesis by ribosomes in cell-free systems.
Topics: Amino Acids; Animals; Carbon Isotopes; Cell-Free System; Centrifugation, Density Gradient; Chromatography, Gel; Chromatography, Ion Exchange; Cytosol; Diabetes Mellitus; Leucine; Male; Muscle Proteins; Muscles; Phenylalanine; Protein Biosynthesis; Rats; Ribosomes; RNA, Transfer; Streptozocin; Transfer RNA Aminoacylation | 1973 |
Hormonal requirements for acute stimulation of rat liver polysome formation by amino acid feeding.
Topics: Adrenal Glands; Adrenalectomy; Amino Acids; Animals; Carbon Radioisotopes; Centrifugation, Density Gradient; Diabetes Mellitus; Evaluation Studies as Topic; Growth Hormone; Hypophysectomy; Insulin; Leucine; Liver; Magnesium; Male; Methods; Phenylalanine; Pituitary Gland; Polyribosomes; Protein Biosynthesis; Rats; Streptozocin; Time Factors; Tritium; Valine | 1974 |
Changes of free amino acids in pancreatic beta-cells after starvation and substrate deprivation.
Topics: Alanine; Amino Acids; Aminobutyrates; Animals; Aspartic Acid; Carbon Radioisotopes; Chromatography, Thin Layer; Dansyl Compounds; Diabetes Mellitus; Fasting; Female; Freeze Drying; Glutamates; Glycine; Islets of Langerhans; Leucine; Lysine; Mice; Obesity; Ornithine; Phenylalanine; Proline; Taurine; Tritium; Valine | 1974 |
Protein synthesis in a postmitochondrial supernatant system from rat liver. An effect of diabetes at the level of peptide chain initiation.
Topics: Animals; Benzoates; Carbon Radioisotopes; Cyclohexanecarboxylic Acids; Diabetes Mellitus; Inosine Nucleotides; Insulin; Kinetics; Leucine; Liver; Male; Peptide Chain Initiation, Translational; Phenols; Phenylalanine; Polynucleotides; Protein Biosynthesis; Rats; Subcellular Fractions | 1973 |
Misleading correlations in clinical applications.
Topics: Cholesterol; Diabetes Mellitus; Humans; Lipoproteins; Phenylalanine; Statistics as Topic; Triglycerides | 1972 |
Effect of diabetes on the activity of soluble factors required in protein synthesis.
Topics: Adenosine Triphosphate; Amino Acyl-tRNA Synthetases; Animals; Carbon Isotopes; Diabetes Mellitus; Guanosine Triphosphate; Liver; Male; Microsomes, Liver; Pancreas; Pancreatectomy; Phenylalanine; Poly U; Protein Biosynthesis; Rats; Ribosomes; Subcellular Fractions | 1972 |
Effect of experimental diabetes mellitus on kidney ribosomal protein synthesis.
Topics: Animals; Carbon Isotopes; Diabetes Mellitus; Diabetes Mellitus, Experimental; Female; Glucosamine; Injections, Intraperitoneal; Insulin Antibodies; Kidney; Liver; Magnesium; Nitrosourea Compounds; Phenylalanine; Protein Biosynthesis; Rats; Ribosomes; RNA, Messenger; RNA, Ribosomal; Time Factors; Tritium; Ultracentrifugation; Uracil Nucleotides | 1971 |
[Serum carboxypeptidases in inflammatory illnesses].
Topics: Adolescent; Anilides; Bronchitis; Carboxypeptidases; Child; Child, Preschool; Colitis, Ulcerative; Diabetes Mellitus; Dipeptides; Gastroenteritis; Humans; Inflammation; Leucyl Aminopeptidase; Leukemia, Lymphoid; Leukemia, Myeloid; Phenylalanine; Pneumonia; Rheumatic Fever; Virus Diseases | 1969 |